MedTrace Logo

Genetic Study in Patients With Stage II or Stage III Colon Cancer

NCT00003833 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 598

Last updated 2016-07-13

No results posted yet for this study

Summary

RATIONALE: Genetic studies may help in understanding the genetic processes that cause some types of cancer.

PURPOSE: Genetic trial to study certain genes of patients who have stage II or stage III colon cancer.

Conditions

Interventions

GENETIC

DNA stability analysis

GENETIC

gene mapping

Sponsors & Collaborators

  • National Cancer Institute (NCI)

    collaborator NIH

  • NCIC Clinical Trials Group

    collaborator NETWORK

  • Alliance for Clinical Trials in Oncology

    lead OTHER

Principal Investigators

  • Richard M. Goldberg, MD · Mayo Clinic

Eligibility

Max Age
69 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
1999-02-28
Primary Completion
2006-08-31
Completion
2006-08-31

Countries

  • United States
  • Canada

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00003833 on ClinicalTrials.gov